Recent advances in the synthesis of Quinazoline analogues as Anti-TB agents.

[1]  C. Bonde,et al.  Design, synthesis and biological evaluation of novel 6-(trifluoromethyl)-N-(4-oxothiazolidin-3-yl)quinazoline-2-carboxamide derivatives as a potential DprE1 inhibitors , 2020 .

[2]  D. Sriram,et al.  Benzimidazoquinazolines as new potent anti-TB chemotypes: Design, synthesis, and biological evaluation. , 2020, Bioorganic chemistry.

[3]  Arvind Kumar,et al.  Gemini basic ionic liquid as bi-functional catalyst for the synthesis of 2,3-dihydroquinazolin-4(1H)-ones at room temperature , 2020 .

[4]  S. Cole,et al.  New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis , 2020, PLoS pathogens.

[5]  Anurag,et al.  Quinazolinone novel derivatives synthesis and their Biological Evaluation as Antimicrobial and Antitubercular agents , 2019, International Journal of Research in Pharmaceutical Sciences.

[6]  Arvind Kumar,et al.  KOH/DMSO: A basic suspension for transition metal-free Tandem synthesis of 2,3-dihydroquinazolin-4(1H)-ones , 2019, Tetrahedron Letters.

[7]  T. R. Swaroop,et al.  Facile synthesis of 1,4-benzodiazepine-2,5-diones and quinazolinones from amino acids as anti-tubercular agents , 2019, New Journal of Chemistry.

[8]  M. Farooqui,et al.  Overview on Nitrogen containing compounds and their assessment based on ‘International Regulatory Standards’ , 2018, Journal of Drug Delivery and Therapeutics.

[9]  A. Shafiee,et al.  Palladium functionalized phosphinite polyethyleneimine grafted magnetic silica nanoparticles as an efficient catalyst for the synthesis of isoquinolino[1,2-b]quinazolin-8-ones , 2018 .

[10]  G. Bemis,et al.  Mtb PKNA/PKNB Dual Inhibition Provides Selectivity Advantages for Inhibitor Design To Minimize Host Kinase Interactions. , 2017, ACS medicinal chemistry letters.

[11]  K. Chandrasekhar,et al.  Efficient synthesis of 2,3-dihydroquinazolin-4(1H)-ones catalyzed by titanium silicon oxide nanopowder in aqueous media , 2017 .

[12]  B. Scheiper,et al.  Identification and optimization of a new series of anti-tubercular quinazolinones. , 2016, Bioorganic & medicinal chemistry letters.

[13]  C. Cabrele,et al.  The Modern Face of Synthetic Heterocyclic Chemistry. , 2016, The Journal of organic chemistry.

[14]  P. Yogeeswari,et al.  Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as anti-tubercular agents. , 2016, Bioorganic & medicinal chemistry letters.

[15]  Jie Wang,et al.  Quinazoline Synthesis via Rh(III)-Catalyzed Intermolecular C-H Functionalization of Benzimidates with Dioxazolones. , 2016, Organic letters.

[16]  G. Khodarahmi,et al.  Quinazolinone and quinazoline derivatives: recent structures with potent antimicrobial and cytotoxic activities , 2016, Research in pharmaceutical sciences.

[17]  R. Chakraborty,et al.  Implication of Quinazoline-4(3H)-ones in Medicinal Chemistry: A Brief Review , 2016 .

[18]  Jianmin Lu,et al.  The cascade synthesis of quinazolinones and quinazolines using an α-MnO2 catalyst and tert-butyl hydroperoxide (TBHP) as an oxidant. , 2015, Chemical communications.

[19]  G. Sotgiu,et al.  Tuberculosis treatment and drug regimens. , 2015, Cold Spring Harbor perspectives in medicine.

[20]  Moon-Young Yoon,et al.  Synthesis, crystal structure and biological evaluation of substituted quinazolinone benzoates as novel antituberculosis agents targeting acetohydroxyacid synthase. , 2015, European journal of medicinal chemistry.

[21]  S. Srivastava,et al.  Biological activity of Quinazoline : A Review , 2015 .

[22]  Xinzhong Li,et al.  One-pot solvent-free synthesis of 2, 3- disubstituted 4(3H)- quinazolinones catalyzed by long-chain double SO3H-functionalized Brønsted acidic ionic liquids under microwave irradiation , 2015, Journal of the Iranian Chemical Society.

[23]  A. Sivakumar,et al.  Design and synthesis of quinazoline carboxylates against Gram-positive, Gram-negative, fungal pathogenic strains, and Mycobacterium tuberculosis , 2014, Journal of pharmacy & bioallied sciences.

[24]  K. Naresh,et al.  Synthesis of novel isoniazid incorporated styryl quinazolinones as anti-tubercular agents against INH sensitive and MDR M. tuberculosis strains , 2014, Medicinal Chemistry Research.

[25]  C. Cheon,et al.  Synthesis of quinazolinones from anthranilamides and aldehydes via metal-free aerobic oxidation in DMSO , 2014 .

[26]  Shailesh N. Khatri,et al.  2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character. , 2013, Bioorganic & medicinal chemistry letters.

[27]  V. Pathak,et al.  Studies on substituted benzo[h]quinazolines, benzo[g]indazoles, pyrazoles, 2,6-diarylpyridines as anti-tubercular agents. , 2013, Bioorganic & medicinal chemistry letters.

[28]  P. Kumari,et al.  Synthesis and biological evaluation of novel quinazoline derivatives obtained by Suzuki C–C coupling , 2013, Medicinal Chemistry Research.

[29]  Nikunj N. Valand,et al.  Synthesis and biological evaluation of cationic fullerene quinazolinone conjugates and their binding mode with modeled Mycobacterium tuberculosis hypoxanthine-guanine phosphoribosyltransferase enzyme , 2013, Journal of Molecular Modeling.

[30]  Manoj Kumar,et al.  PHYTOCHEMICAL SCREENING AND ANTIOXIDANT POTENCY OF ADHATODA VASICA AND VITEX NEGUNDO , 2013 .

[31]  M. Srivastav,et al.  Design and Synthesis of Novel 2-Trichloromethyl-4- Substituted Quinazoline Derivatives as Anti-tubercular Agents , 2013 .

[32]  A. Dodiya,et al.  Synthesis and antitubercular activity of novel pyrazole–quinazolinone hybrid analogs , 2012, Medicinal Chemistry Research.

[33]  G. Shankarling,et al.  Bio-compatible eutectic mixture for multi-component synthesis: A valuable acidic catalyst for synthesis of novel 2,3-dihydroquinazolin-4(1H)-one derivatives , 2012 .

[34]  A. El-Azab,et al.  Design and synthesis of novel 7-aminoquinazoline derivatives: antitumor and anticonvulsant activities. , 2012, Bioorganic & medicinal chemistry letters.

[35]  T. Chou,et al.  Design, synthesis and antitumor evaluation of phenyl N-mustard-quinazoline conjugates. , 2011, Bioorganic & medicinal chemistry.

[36]  A. Trivedi,et al.  Synthesis, Characterization and Biological Screening of Some Novel Tetrahydroquinazoline Derivatives. , 2010 .

[37]  S. Rajasekaran,et al.  Synthesis, antitubercular, antibacterial and antioxidant activity of some 2-phenyl-3-substituted quinazolin-4(3H)-ones , 2010 .

[38]  V. Alagarsamy,et al.  3‐(3‐Ethylphenyl)‐2‐substituted hydrazino‐3H‐quinazolin‐4‐one Derivatives: New Class of Analgesic and Anti‐Inflammatory Agents , 2009, Chemical biology & drug design.

[39]  T. Yakaiah,et al.  Synthesis of novel 4,6-disubstituted quinazoline derivatives, their anti-inflammatory and anti-cancer activity (cytotoxic) against U937 leukemia cell lines. , 2008, European journal of medicinal chemistry.

[40]  V. Alagarsamy,et al.  Design and synthesis of 3-(4-Ethylphenyl)-2-substituted amino-3H-quinazolin-4-ones as a novel class of analgesic and anti-inflammatory agents , 2008, Journal of enzyme inhibition and medicinal chemistry.

[41]  S. Rault,et al.  Synthesis and antiplasmodial activity of new 4-aryl-2-trichloromethylquinazolines. , 2008, Bioorganic & medicinal chemistry letters.

[42]  Yves L Janin,et al.  Antituberculosis drugs: ten years of research. , 2007, Bioorganic & medicinal chemistry.

[43]  F. Manvi,et al.  Synthesis of N‐3[4‐(4‐Chlorophenyl) thiazole‐2‐yl]‐2‐(aminomethyl)quinazoline‐4(3H)‐one and Their Derivatives for Antitubercular Activity. , 2006 .

[44]  S. Kini,et al.  Synthesis and evaluation of new quinazolone derivatives of nalidixic acid as potential antibacterial and antifungal agents. , 2006, European journal of medicinal chemistry.

[45]  M. Dabiri,et al.  Water-Accelerated Synthesis of Novel Bis-2,3-dihydroquinazolin-4(1H)-one Derivatives , 2006 .

[46]  P. Guiry,et al.  Synthesis of Quinazolinones and Quinazolines , 2005 .

[47]  M. Dabiri,et al.  Efficient synthesis of mono- and disubstituted 2,3-dihydroquinazolin-4(1H)-ones using KAl(SO4)2·12H2O as a reusable catalyst in water and ethanol , 2005 .

[48]  M. Zolfigol,et al.  A Novel Method for the One-Pot Three-Component Synthesis of 2,3-Dihydroquinazolin-4(1H)-ones , 2005 .

[49]  D. Shi,et al.  An efficient synthesis of quinazoline derivatives with the aid of low‐valent titanium reagent , 2005 .

[50]  A. Okunade,et al.  Natural antimycobacterial metabolites: current status. , 2004, Phytochemistry.

[51]  S. Da.  Synthesis of 1,2-Dihydroquinazolin-4(3H)-ones Promoted by Low-valent Titanium , 2004 .

[52]  D. Shi,et al.  Synthesis of quinazolin-4(3H)-ones and 1,2-dihydroquinazolin-4(3H)-ones with the aid of a low-valent titanium reagent , 2003 .

[53]  P. Lu,et al.  A one‐pot synthesis of 2‐aryl‐2,3‐dihydro‐4(lH)‐quinazolinones by use of samarium iodide , 2002 .

[54]  W. Su,et al.  Reductive Cyclization of Nitro and Azide Compounds with Aldehydes and Ketones Promoted by Metallic Samarium and Catalytic Amount of Iodine , 2002 .

[55]  J. Kuneš,et al.  Quinazoline derivatives with antitubercular activity. , 2000, Farmaco.

[56]  J. Grange,et al.  Activity of bromhexine and ambroxol, semi-synthetic derivatives of vasicine from the Indian shrub Adhatoda vasica, against Mycobacterium tuberculosis in vitro. , 1996, Journal of ethnopharmacology.

[57]  M. Malamas,et al.  Quinazolineacetic acids and related analogues as aldose reductase inhibitors. , 1991, Journal of medicinal chemistry.

[58]  S. Sharma,et al.  Synthesis of 3-Oxa- and 3-Aza-1-dethiacepham Analogs , 1990 .

[59]  H. Asakawa,et al.  Chemistry of salicylic acid and anthranilic acid. IV. Synthesis of 6-chloro-5-sulfamoyl- and 6-chloro-3-sulfamoylanthranilic acid derivatives. , 1979, Chemical & pharmaceutical bulletin.

[60]  G. J. Sutherland,et al.  Reactions of anthranilamide and o-aminoacetophenone with benzil and benzoin , 1969 .

[61]  S. Niementowski.  Synthesen von Chinazolinverbindungen , 1894 .